bluuebunny/crossref_metadata_2025 huggingface dataset:
Figure S4 from Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade
Authors: House Imran G. , Savas Peter , Lai Junyun , Chen Amanda X.Y. , Oliver Amanda J. , Teo Zhi L. , Todd Kirsten L. , Henderson Melissa A. , Giuffrida Lauren , Petley Emma V. , Sek Kevin , Mardiana Sherly , Gide Tuba N. , Quek Camelia , Scolyer Richard A. , Long Georgina V. , Wilmott James S. , Loi Sherene , Darcy Phillip K. , Beavis Paul A.
Published: April 2023

Figure S4 shows the effect of CXCR3 blockade on the number and phenotype of tumor-infiltrating immune cells post combination therapy
Figure S3 from Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade
Authors: House Imran G. , Savas Peter , Lai Junyun , Chen Amanda X.Y. , Oliver Amanda J. , Teo Zhi L. , Todd Kirsten L. , Henderson Melissa A. , Giuffrida Lauren , Petley Emma V. , Sek Kevin , Mardiana Sherly , Gide Tuba N. , Quek Camelia , Scolyer Richard A. , Long Georgina V. , Wilmott James S. , Loi Sherene , Darcy Phillip K. , Beavis Paul A.
Published: April 2023

Figure S3 shows the association between the expression of chemokines/ chemokine receptors and patient prognosis and immune cell infiltrate.
Figure S2 from Genetic Ancestry–dependent Differences in Breast Cancer–induced Field Defects in the Tumor-adjacent Normal Breast
Authors: Nakshatri Harikrishna , Kumar Brijesh , Burney Heather N. , Cox Mary L. , Jacobsen Max , Sandusky George E. , D'Souza-Schorey Crislyn , Storniolo Anna Maria V.
Published: April 2023

GATA3 expression pattern
Supplementary Figures 1-5 from Differential Sensitivity Analysis for Resistant Malignancies (DISARM) Identifies Common Candidate Therapies across Platinum-Resistant Cancers
Authors: Gay Carl M. , Tong Pan , Cardnell Robert J. , Sen Triparna , Su Xiao , Ma Jun , Bara Rasha O. , Johnson Faye M. , Wakefield Chris , Heymach John V. , Wang Jing , Byers Lauren A.
Published: April 2023

Supplementary Figure S1. Step-by-step user guide for DISARM application â€" Part 1; Supplementary Figure S2. Step-by-step user guide for DISARM web application â€" Part 2; Supplementary Figure S3. Comparison of DISARM-selected candidates from GDSC in cisplatinsensitive and â€"resistant models identifies numerous drugs that are more effective in cisplatinresistant models; Supplementary Figure S4. Cisplatin-resistance in SCLC, both de novo and acquired, is associated with increased expression of RAF-MEK-ERK (MAPK) pathway, a target predicted by DISARM; Supplementary Figure S5. Cisplatin-resistant SCLC models not previously analyzed by DISARM are sensitive to DISARM candidates.
Table S1 from Inferring the Evolution and Progression of Small-Cell Lung Cancer by Single-Cell Sequencing of Circulating Tumor Cells
Authors: Su Zhe , Wang Zhijie , Ni Xiaohui , Duan Jianchun , Gao Yan , Zhuo Minglei , Li Ruoyan , Zhao Jun , Ma Qi , Bai Hua , Chen Hengyu , Wang Shuhang , Chen Xixi , An Tongtong , Wang Yuyan , Tian Yanhua , Yu Jiangyong , Wang Di , Xie Xiaoliang Sunney , Bai Fan , Wang Jie
Published: April 2023

supplementary Table 1
Figure S1-S6 from Inferring the Evolution and Progression of Small-Cell Lung Cancer by Single-Cell Sequencing of Circulating Tumor Cells
Authors: Su Zhe , Wang Zhijie , Ni Xiaohui , Duan Jianchun , Gao Yan , Zhuo Minglei , Li Ruoyan , Zhao Jun , Ma Qi , Bai Hua , Chen Hengyu , Wang Shuhang , Chen Xixi , An Tongtong , Wang Yuyan , Tian Yanhua , Yu Jiangyong , Wang Di , Xie Xiaoliang Sunney , Bai Fan , Wang Jie
Published: April 2023

Supplementary Figures 1-6
Table S4 from The Senescence-associated Secretory Phenotype Mediates Oncogene-induced Senescence in Pediatric Pilocytic Astrocytoma
Authors: Buhl Juliane L. , Selt Florian , Hielscher Thomas , Guiho Romain , Ecker Jonas , Sahm Felix , Ridinger Johannes , Riehl Dennis , Usta Diren , Ismer Britta , Sommerkamp Alexander C. , Martinez-Barbera J.P. , Wefers Annika K. , Remke Marc , Picard Daniel , Pusch Stefan , Gronych Jan , Oehme Ina , van Tilburg Cornelis M. , Kool Marcel , Kuhn Daniela , Capper David , von Deimling Andreas , Schuhmann Martin U. , Herold-Mende Christel , Korshunov Andrey , Brummer Tilman , Pfister Stefan M. , Jones David T.W. , Witt Olaf , Milde Till
Published: April 2023

Clinical annotations of the PA patient cohort
Figure S1 from HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor, in Patients with Clear Cell Renal Cell Carcinoma
Authors: Courtney Kevin D. , Ma Yuanqing , Diaz de Leon Alberto , Christie Alana , Xie Zhiqun , Woolford Layton , Singla Nirmish , Joyce Allison , Hill Haley , Madhuranthakam Ananth J. , Yuan Qing , Xi Yin , Zhang Yue , Chang Jenny , Fatunde Oluwatomilade , Arriaga Yull , Frankel Arthur E. , Kalva Sanjeeva , Zhang Song , McKenzie Tiffani , Reig Torras Oscar , Figlin Robert A. , Rini Brian I. , McKay Renée M. , Kapur Payal , Wang Tao , Pedrosa Ivan , Brugarolas James
Published: April 2023

Supplementary Figure S1. Pharmacodynamic analyses and illustrative mpMRI studies.
Figure S3 from Clinical Response of Live-Attenuated, Listeria monocytogenes Expressing Mesothelin (CRS-207) with Chemotherapy in Patients with Malignant Pleural Mesothelioma
Authors: Hassan Raffit , Alley Evan , Kindler Hedy , Antonia Scott , Jahan Thierry , Honarmand Somayeh , Nair Nitya , Whiting Chan C. , Enstrom Amanda , Lemmens Ed , Tsujikawa Takahiro , Kumar Sushil , Choe Gina , Thomas Anish , McDougall Katherine , Murphy Aimee L. , Jaffee Elizabeth , Coussens Lisa M. , Brockstedt Dirk G.
Published: April 2023

Image cytometry gating strategy for multi-plex IHC analysis of mesothelioma biopsies
Tables S1 to S13 from Identification of Recurrent Activating HER2 Mutations in Primary Canine Pulmonary Adenocarcinoma
Authors: Lorch Gwendolen , Sivaprakasam Karthigayini , Zismann Victoria , Perdigones Nieves , Contente-Cuomo Tania , Nazareno Alexandra , Facista Salvatore , Wong Shukmei , Drenner Kevin , Liang Winnie S. , Amann Joseph M. , Sinicropi-Yao Sara L. , Koenig Michael J. , La Perle Krista , Whitsett Timothy G. , Murtaza Muhammed , Trent Jeffrey M. , Carbone David P. , Hendricks William P.D.
Published: April 2023

Supplementary Table 1. Informatic tools utilized in primary canine lung cancer analysis Supplementary Table 2. Extended clinical and multiplatform annotation of primary canine lung cancer cases. Supplementary Table 3 : Sequencing metrics for primary canine lung cancer exome analysis. Supplementary Table 4. Somatic coding SNVs identified by exome sequencing of primary canine lung cancers. Supplementary Table 5. Somatic copy number variants identified by exome sequencing in primary canine lung cancers. Supplementary Table 6. Somatic coding structural variants identified by exome sequencing of primary canine lung cancers. Supplementary Table 7. Canine genomic regions covered by custom amplicon panel. Supplementary Table 8. Sequencing metrics for primary canine lung cancer amplicon analysis. Supplementary Table 9. Somatic coding SNVs identified by panel sequencing of primary canine lung cancers. Supplementary Table 10. Germline SNPs in COSMIC Tier 1 cancer genes identified by exome and panel sequencing in primary canine lung cancers. Supplementary Table 11. Multi-platform validation of HER2 mutations. Supplementary Table 12. Non-invasive detection of HER2V659E in the plasma of primary canine lung cancer patients. Supplementary Table 13. HER2 protein expression and quantification by immunohistochemistry.
Table S1 from Mast Cell Activation and KSHV Infection in Kaposi Sarcoma
Authors: Ayers Leona W. , Barbachano-Guerrero Arturo , McAllister Shane C. , Ritchie Julie A. , Asiago-Reddy Elizabeth , Bartlett Linda C. , Cesarman Ethel , Wang Dongliang , Rochford Rosemary , Martin Jeffrey N. , King Christine A.
Published: April 2023

Table of primer sequences
Supplementary Figure S8 from A CpG Methylation Classifier to Predict Relapse in Adults with T-Cell Lymphoblastic Lymphoma
Authors: Tian Xiao-Peng , Su Ning , Wang Liang , Huang Wei-Juan , Liu Yan-Hui , Zhang Xi , Huang Hui-Qiang , Lin Tong-Yu , Ma Shu-Yun , Rao Hui-Lan , Li Mei , Liu Fang , Zhang Fen , Zhong Li-Ye , Liang Li , Lan Xiao-Liang , Li Juan , Liao Bing , Li Zhi-Hua , Tang Qiong-Lan , Liang Qiong , Shao Chun-Kui , Zhai Qiong-Li , Cheng Run-Fen , Sun Qi , Ru Kun , Gu Xia , Lin Xi-Na , Yi Kun , Shuang Yue-Rong , Chen Xiao-Dong , Dong Wei , Sun Cai , Sang Wei , Liu Hui , Zhu Zhi-Gang , Rao Jun , Guo Qiao-Nan , Zhou Ying , Meng Xiang-Ling , Zhu Yong , Hu Chang-Lu , Jiang Yi-Rong , Zhang Ying , Gao Hong-Yi , He Wen-Jun , Xia Zhong-Jun , Pan Xue-Yi , Hai Lan , Li Guo-Wei , Song Li-Yan , Kang Tie-Bang , Xie Dan , Cai Qing-Qing
Published: April 2023

Supplementary Figure S8
Supplementary Figure S6 from A CpG Methylation Classifier to Predict Relapse in Adults with T-Cell Lymphoblastic Lymphoma
Authors: Tian Xiao-Peng , Su Ning , Wang Liang , Huang Wei-Juan , Liu Yan-Hui , Zhang Xi , Huang Hui-Qiang , Lin Tong-Yu , Ma Shu-Yun , Rao Hui-Lan , Li Mei , Liu Fang , Zhang Fen , Zhong Li-Ye , Liang Li , Lan Xiao-Liang , Li Juan , Liao Bing , Li Zhi-Hua , Tang Qiong-Lan , Liang Qiong , Shao Chun-Kui , Zhai Qiong-Li , Cheng Run-Fen , Sun Qi , Ru Kun , Gu Xia , Lin Xi-Na , Yi Kun , Shuang Yue-Rong , Chen Xiao-Dong , Dong Wei , Sun Cai , Sang Wei , Liu Hui , Zhu Zhi-Gang , Rao Jun , Guo Qiao-Nan , Zhou Ying , Meng Xiang-Ling , Zhu Yong , Hu Chang-Lu , Jiang Yi-Rong , Zhang Ying , Gao Hong-Yi , He Wen-Jun , Xia Zhong-Jun , Pan Xue-Yi , Hai Lan , Li Guo-Wei , Song Li-Yan , Kang Tie-Bang , Xie Dan , Cai Qing-Qing
Published: April 2023

Supplementary Figure S6
Supplementary Figure S4 from Robust Activity of Avapritinib, Potent and Highly Selective Inhibitor of Mutated KIT, in Patient-derived Xenograft Models of Gastrointestinal Stromal Tumors
Authors: Gebreyohannes Yemarshet K. , Wozniak Agnieszka , Zhai Madalina-Elena , Wellens Jasmien , Cornillie Jasmien , Vanleeuw Ulla , Evans Erica , Gardino Alexandra K. , Lengauer Christoph , Debiec-Rychter Maria , Sciot Raf , Schöffski Patrick
Published: April 2023

Representative images of pHH3 immunostaining (200x magnification), comparing untreated vehicle-treated with imatinib, avapritinib 10 mg/kg or 30 mg/kg treated tumors in three models.
Supplementary Figure S1 from Robust Activity of Avapritinib, Potent and Highly Selective Inhibitor of Mutated KIT, in Patient-derived Xenograft Models of Gastrointestinal Stromal Tumors
Authors: Gebreyohannes Yemarshet K. , Wozniak Agnieszka , Zhai Madalina-Elena , Wellens Jasmien , Cornillie Jasmien , Vanleeuw Ulla , Evans Erica , Gardino Alexandra K. , Lengauer Christoph , Debiec-Rychter Maria , Sciot Raf , Schöffski Patrick
Published: April 2023

Chemical structures of imatinib, sunitinib, regorafenib and avapritinib.
Supplementary Data from DNA Sequencing of Small Bowel Adenocarcinomas Identifies Targetable Recurrent Mutations in the ERBB2 Signaling Pathway
Authors: Adam Liana , San Lucas F. Anthony , Fowler Richard , Yu Yao , Wu Wenhui , Liu Yulun , Wang Huamin , Menter David , Tetzlaff Michael T. , Ensor Joe , Manyam Ganiraju , Arold Stefan T. , Huff Chad , Kopetz Scott , Scheet Paul , Overman Michael J.
Published: April 2023

Table S1
Supplementary Figure S15 from A CpG Methylation Classifier to Predict Relapse in Adults with T-Cell Lymphoblastic Lymphoma
Authors: Tian Xiao-Peng , Su Ning , Wang Liang , Huang Wei-Juan , Liu Yan-Hui , Zhang Xi , Huang Hui-Qiang , Lin Tong-Yu , Ma Shu-Yun , Rao Hui-Lan , Li Mei , Liu Fang , Zhang Fen , Zhong Li-Ye , Liang Li , Lan Xiao-Liang , Li Juan , Liao Bing , Li Zhi-Hua , Tang Qiong-Lan , Liang Qiong , Shao Chun-Kui , Zhai Qiong-Li , Cheng Run-Fen , Sun Qi , Ru Kun , Gu Xia , Lin Xi-Na , Yi Kun , Shuang Yue-Rong , Chen Xiao-Dong , Dong Wei , Sun Cai , Sang Wei , Liu Hui , Zhu Zhi-Gang , Rao Jun , Guo Qiao-Nan , Zhou Ying , Meng Xiang-Ling , Zhu Yong , Hu Chang-Lu , Jiang Yi-Rong , Zhang Ying , Gao Hong-Yi , He Wen-Jun , Xia Zhong-Jun , Pan Xue-Yi , Hai Lan , Li Guo-Wei , Song Li-Yan , Kang Tie-Bang , Xie Dan , Cai Qing-Qing
Published: April 2023

Supplementary Figure S15
Supplementary Data from DNA Sequencing of Small Bowel Adenocarcinomas Identifies Targetable Recurrent Mutations in the ERBB2 Signaling Pathway
Authors: Adam Liana , San Lucas F. Anthony , Fowler Richard , Yu Yao , Wu Wenhui , Liu Yulun , Wang Huamin , Menter David , Tetzlaff Michael T. , Ensor Joe , Manyam Ganiraju , Arold Stefan T. , Huff Chad , Kopetz Scott , Scheet Paul , Overman Michael J.
Published: April 2023

Table S3
Supplementary Figure S13 from A CpG Methylation Classifier to Predict Relapse in Adults with T-Cell Lymphoblastic Lymphoma
Authors: Tian Xiao-Peng , Su Ning , Wang Liang , Huang Wei-Juan , Liu Yan-Hui , Zhang Xi , Huang Hui-Qiang , Lin Tong-Yu , Ma Shu-Yun , Rao Hui-Lan , Li Mei , Liu Fang , Zhang Fen , Zhong Li-Ye , Liang Li , Lan Xiao-Liang , Li Juan , Liao Bing , Li Zhi-Hua , Tang Qiong-Lan , Liang Qiong , Shao Chun-Kui , Zhai Qiong-Li , Cheng Run-Fen , Sun Qi , Ru Kun , Gu Xia , Lin Xi-Na , Yi Kun , Shuang Yue-Rong , Chen Xiao-Dong , Dong Wei , Sun Cai , Sang Wei , Liu Hui , Zhu Zhi-Gang , Rao Jun , Guo Qiao-Nan , Zhou Ying , Meng Xiang-Ling , Zhu Yong , Hu Chang-Lu , Jiang Yi-Rong , Zhang Ying , Gao Hong-Yi , He Wen-Jun , Xia Zhong-Jun , Pan Xue-Yi , Hai Lan , Li Guo-Wei , Song Li-Yan , Kang Tie-Bang , Xie Dan , Cai Qing-Qing
Published: April 2023

Supplementary Figure S13
Supplementary Figure S10 from A CpG Methylation Classifier to Predict Relapse in Adults with T-Cell Lymphoblastic Lymphoma
Authors: Tian Xiao-Peng , Su Ning , Wang Liang , Huang Wei-Juan , Liu Yan-Hui , Zhang Xi , Huang Hui-Qiang , Lin Tong-Yu , Ma Shu-Yun , Rao Hui-Lan , Li Mei , Liu Fang , Zhang Fen , Zhong Li-Ye , Liang Li , Lan Xiao-Liang , Li Juan , Liao Bing , Li Zhi-Hua , Tang Qiong-Lan , Liang Qiong , Shao Chun-Kui , Zhai Qiong-Li , Cheng Run-Fen , Sun Qi , Ru Kun , Gu Xia , Lin Xi-Na , Yi Kun , Shuang Yue-Rong , Chen Xiao-Dong , Dong Wei , Sun Cai , Sang Wei , Liu Hui , Zhu Zhi-Gang , Rao Jun , Guo Qiao-Nan , Zhou Ying , Meng Xiang-Ling , Zhu Yong , Hu Chang-Lu , Jiang Yi-Rong , Zhang Ying , Gao Hong-Yi , He Wen-Jun , Xia Zhong-Jun , Pan Xue-Yi , Hai Lan , Li Guo-Wei , Song Li-Yan , Kang Tie-Bang , Xie Dan , Cai Qing-Qing
Published: April 2023

Supplementary Figure S10
Figures S1-4 from A Novel, Fully Human Anti–fucosyl-GM1 Antibody Demonstrates Potent In Vitro and In Vivo Antitumor Activity in Preclinical Models of Small Cell Lung Cancer
Authors: Ponath Paul , Menezes Daniel , Pan Chin , Chen Bing , Oyasu Miho , Strachan Debbie , LeBlanc Heidi , Sun Huadong , Wang Xi-Tao , Rangan Vangipuram S. , Deshpande Shrikant , Cristea Sandra , Park Kwon-Sik , Sage Julien , Cardarelli Pina M.
Published: April 2023

4 suppl figures on tumor models
Table S3 from The Immune Microenvironment and Neoantigen Landscape of Aggressive Salivary Gland Carcinomas Differ by Subtype
Authors: Linxweiler Maximilian , Kuo Fengshen , Katabi Nora , Lee Mark , Nadeem Zaineb , Dalin Martin G. , Makarov Vladimir , Chowell Diego , Dogan Snjezana , Ganly Ian , Hakimi A. Ari , Wong Richard J. , Riaz Nadeem , Ho Alan L. , Chan Timothy A. , Morris Luc G.T.
Published: April 2023

Table S3
Figure S1 from Comparing Circulating Tumor Cell Counts with Dynamic Tumor Size Changes as Predictor of Overall Survival: A Quantitative Modeling Framework
Authors: Netterberg Ida , Karlsson Mats O. , Terstappen Leon W.M.M. , Koopman Miriam , Punt Cornelis J.A. , Friberg Lena E.
Published: April 2023

Summary of number of patients and reasons for exclusion from the analysis data set.
Figure S7 from The Immune Microenvironment and Neoantigen Landscape of Aggressive Salivary Gland Carcinomas Differ by Subtype
Authors: Linxweiler Maximilian , Kuo Fengshen , Katabi Nora , Lee Mark , Nadeem Zaineb , Dalin Martin G. , Makarov Vladimir , Chowell Diego , Dogan Snjezana , Ganly Ian , Hakimi A. Ari , Wong Richard J. , Riaz Nadeem , Ho Alan L. , Chan Timothy A. , Morris Luc G.T.
Published: April 2023

Figure S7
Figure S5 from The Immune Microenvironment and Neoantigen Landscape of Aggressive Salivary Gland Carcinomas Differ by Subtype
Authors: Linxweiler Maximilian , Kuo Fengshen , Katabi Nora , Lee Mark , Nadeem Zaineb , Dalin Martin G. , Makarov Vladimir , Chowell Diego , Dogan Snjezana , Ganly Ian , Hakimi A. Ari , Wong Richard J. , Riaz Nadeem , Ho Alan L. , Chan Timothy A. , Morris Luc G.T.
Published: April 2023

Figure S5
Figure S1 from The Immune Microenvironment and Neoantigen Landscape of Aggressive Salivary Gland Carcinomas Differ by Subtype
Authors: Linxweiler Maximilian , Kuo Fengshen , Katabi Nora , Lee Mark , Nadeem Zaineb , Dalin Martin G. , Makarov Vladimir , Chowell Diego , Dogan Snjezana , Ganly Ian , Hakimi A. Ari , Wong Richard J. , Riaz Nadeem , Ho Alan L. , Chan Timothy A. , Morris Luc G.T.
Published: April 2023

Figure S1
Supplementary Figure S1 from Phase I Study of Rapid Alternation of Sunitinib and Regorafenib for the Treatment of Tyrosine Kinase Inhibitor Refractory Gastrointestinal Stromal Tumors
Authors: Serrano César , Leal Alessandro , Kuang Yanan , Morgan Jeffrey A. , Barysauskas Constance M. , Phallen Jillian , Triplett Olivia , Mariño-Enríquez Adrián , Wagner Andrew J. , Demetri George D. , Velculescu Victor E. , Paweletz Cloud P. , Fletcher Jonathan A. , George Suzanne
Published: April 2023

Sunitinib (A) and Regorafenib (B) plasma concentration (ng/mL) across several timepoints during cycle 1.
Supplementary Data from Clinical Significance of Extracellular Vesicles in Plasma from Glioblastoma Patients
Authors: Osti Daniela , Del Bene Massimiliano , Rappa Germana , Santos Mark , Matafora Vittoria , Richichi Cristina , Faletti Stefania , Beznoussenko Galina V. , Mironov Alexandre , Bachi Angela , Fornasari Lorenzo , Bongetta Daniele , Gaetani Paolo , DiMeco Francesco , Lorico Aurelio , Pelicci Giuliana
Published: April 2023

Figure S2
Supplementary Figure 4 from The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia
Authors: Verbeke Delphine , Demeyer Sofie , Prieto Cristina , de Bock Charles E. , De Bie Jolien , Gielen Olga , Jacobs Kris , Mentens Nicole , Verhoeven Bronte Manouk , Uyttebroeck Anne , Boeckx Nancy , De Keersmaecker Kim , Maertens Johan , Segers Heidi , Cools Jan
Published: April 2023

Suppl. figure 4: KPT-8602 single treatment or combined treatment with dexamethasone does not lead to nuclear accumulation of IKBα nor to effects on NFκB target genes
Supplementary Figure 7 from A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination–deficient Pancreatic Cancer
Authors: Wang Yifan , Park Jin Yong Patrick , Pacis Alain , Denroche Robert E. , Jang Gun Ho , Zhang Amy , Cuggia Adeline , Domecq Celine , Monlong Jean , Raitses-Gurevich Maria , Grant Robert C. , Borgida Ayelet , Holter Spring , Stossel Chani , Bu Simeng , Masoomian Mehdi , Lungu Ilinca M. , Bartlett John M.S. , Wilson Julie M. , Gao Zu-Hua , Riazalhosseini Yasser , Asselah Jamil , Bouganim Nathaniel , Cabrera Tatiana , Boucher Louis-Martin , Valenti David , Biagi James , Greenwood Celia M.T. , Polak Paz , Foulkes William D. , Golan Talia , O'Kane Grainne M. , Fischer Sandra E. , Knox Jennifer J. , Gallinger Steven , Zogopoulos George
Published: April 2023

Supplementary Figure 7 shows the comparison of COSMIC SBS mutational signatures between untreated parent xenografts vs. xenografts treated with gemcitabine-cisplatin
Supplemental Figure 1 from Multicenter Phase I Trial of a DNA Vaccine Encoding the Androgen Receptor Ligand-binding Domain (pTVG-AR, MVI-118) in Patients with Metastatic Prostate Cancer
Authors: Kyriakopoulos Christos E. , Eickhoff Jens C. , Ferrari Anna C. , Schweizer Michael T. , Wargowski Ellen , Olson Brian M. , McNeel Douglas G.
Published: April 2023

Supplemental Figure 1: T-cell immunological response to PSA over time: Panel A: IFNγ ELISPOT data, similar to that as shown in Figure 3, were plotted over time, subtracting the pre-treatment value, to evaluate the magnitude and durability of immunity over time. Panel B: Immune response over time was plotted as "area under the curve," and evaluated with respect to treatment arm. Lines show median and interquartile range.
Supplementary Figure S7 from TSPO-targeted PET and Optical Probes for the Detection and Localization of Premalignant and Malignant Pancreatic Lesions
Authors: Cohen Allison S. , Li Jun , Hight Matthew R. , McKinley Eliot , Fu Allie , Payne Adria , Liu Yang , Zhang Dawei , Xie Qing , Bai Mingfeng , Ayers Gregory D. , Tantawy Mohammed Noor , Smith Jarrod A. , Revetta Frank , Washington M. Kay , Shi Chanjuan , Merchant Nipun , Manning H. Charles
Published: April 2023

Fluorescence microscopy of pancreatic lesions using V-1520
Supplementary Figure S3 from TSPO-targeted PET and Optical Probes for the Detection and Localization of Premalignant and Malignant Pancreatic Lesions
Authors: Cohen Allison S. , Li Jun , Hight Matthew R. , McKinley Eliot , Fu Allie , Payne Adria , Liu Yang , Zhang Dawei , Xie Qing , Bai Mingfeng , Ayers Gregory D. , Tantawy Mohammed Noor , Smith Jarrod A. , Revetta Frank , Washington M. Kay , Shi Chanjuan , Merchant Nipun , Manning H. Charles
Published: April 2023

White light images of mouse tissues
Supplementary Data from CXCR3 and Cognate Ligands are Associated with Immune Cell Alteration and Aggressiveness of Pancreatic Ductal Adenocarcinoma
Authors: Cannon Andrew , Thompson Christopher M. , Maurer H. Carlo , Atri Pranita , Bhatia Rakesh , West Sean , Ghersi Dario , Olive Kenneth P. , Kumar Sushil , Batra Surinder K.
Published: April 2023

Supplementary Figure Legends.
Supplementary Figure S1 from TSPO-targeted PET and Optical Probes for the Detection and Localization of Premalignant and Malignant Pancreatic Lesions
Authors: Cohen Allison S. , Li Jun , Hight Matthew R. , McKinley Eliot , Fu Allie , Payne Adria , Liu Yang , Zhang Dawei , Xie Qing , Bai Mingfeng , Ayers Gregory D. , Tantawy Mohammed Noor , Smith Jarrod A. , Revetta Frank , Washington M. Kay , Shi Chanjuan , Merchant Nipun , Manning H. Charles
Published: April 2023

[18F]V-1008 localization observed in Ptf1a-Cre;LSL-KrasG12D/+;Tgfbr2+/- (KTC) pancreatic lesions
Figure S4 from CXCR3 and Cognate Ligands are Associated with Immune Cell Alteration and Aggressiveness of Pancreatic Ductal Adenocarcinoma
Authors: Cannon Andrew , Thompson Christopher M. , Maurer H. Carlo , Atri Pranita , Bhatia Rakesh , West Sean , Ghersi Dario , Olive Kenneth P. , Kumar Sushil , Batra Surinder K.
Published: April 2023

CXCR3 expression in microarray data and high and low cellularity in TCGA dataset.
Supplementary Data from Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic Heterogeneity
Authors: Bruun Jarle , Kryeziu Kushtrim , Eide Peter W. , Moosavi Seyed H. , Eilertsen Ina A. , Langerud Jonas , Røsok Bård , Totland Max Z. , Brunsell Tuva H. , Pellinen Teijo , Saarela Jani , Bergsland Christian H. , Palmer Hector G. , Brudvik Kristoffer W. , Guren Tormod , Dienstmann Rodrigo , Guren Marianne G. , Nesbakken Arild , Bjørnbeth Bjørn Atle , Sveen Anita , Lothe Ragnhild A.
Published: April 2023

Supplementary methods, materials and figures
Figure S1 from CXCR3 and Cognate Ligands are Associated with Immune Cell Alteration and Aggressiveness of Pancreatic Ductal Adenocarcinoma
Authors: Cannon Andrew , Thompson Christopher M. , Maurer H. Carlo , Atri Pranita , Bhatia Rakesh , West Sean , Ghersi Dario , Olive Kenneth P. , Kumar Sushil , Batra Surinder K.
Published: April 2023

H&E images for KC and KPC murine models
Supplementary Data from Treatment of Patients with Relapsed or Refractory Mantle–Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton's Tyrosine Kinase
Authors: Song Yuqin , Zhou Keshu , Zou Dehui , Zhou Jianfeng , Hu Jianda , Yang Haiyan , Zhang Huilai , Ji Jie , Xu Wei , Jin Jie , Lv Fangfang , Feng Ru , Gao Sujun , Guo Haiyi , Zhou Lei , Elstrom Rebecca , Huang Jane , Novotny William , Wei Rachel , Zhu Jun
Published: April 2023

Appendix Tables 1-2
Supplementary Figure S3 from Rapid Expansion of Highly Functional Antigen-Specific T Cells from Patients with Melanoma by Nanoscale Artificial Antigen-Presenting Cells
Authors: Ichikawa Junya , Yoshida Tatsuya , Isser Ariel , Laino Andressa S. , Vassallo Melinda , Woods David , Kim Sojung , Oelke Mathias , Jones Kristi , Schneck Jonathan P. , Weber Jeffrey S.
Published: April 2023

Polyfunctional analysis of MART-1 Tet+ CD8+ T-cells expanded by nano-aAPC or DCs.
Supplementary Materials and Methods from CUE-101, a Novel E7-pHLA-IL2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the Treatment of HPV16-Driven Malignancies
Authors: Quayle Steven N. , Girgis Natasha , Thapa Dharma R. , Merazga Zohra , Kemp Melissa M. , Histed Alex , Zhao Fan , Moreta Miguel , Ruthardt Paige , Hulot Sandrine , Nelson Alyssa , Kraemer Lauren D. , Beal Dominic R. , Witt Luke , Ryabin Jessica , Soriano Jonathan , Haydock Mark , Spaulding Emily , Ross John F. , Kiener Peter A. , Almo Steven , Chaparro Rodolfo , Seidel Ronald , Suri Anish , Cemerski Saso , Pienta Kenneth J. , Simcox Mary Ellen
Published: April 2023

Supplementary Materials and Methods
Supplementary figures description from The Immunosuppressive Niche of Soft-Tissue Sarcomas is Sustained by Tumor-Associated Macrophages and Characterized by Intratumoral Tertiary Lymphoid Structures
Authors: Chen Lingling , Oke Teniola , Siegel Nicholas , Cojocaru Gady , Tam Ada J. , Blosser Richard L. , Swailes Jessica , Ligon John A. , Lebid Andriana , Morris Carol , Levin Adam , Rhee Daniel S. , Johnston Fabian M. , Greer Jonathan B. , Meyer Christian F. , Ladle Brian H. , Thompson Elizabeth D. , Montgomery Elizabeth A. , Choi Woonyoung , McConkey David J. , Anders Robert A. , Pardoll Drew M. , Llosa Nicolas J.
Published: April 2023

Supplemental Figures description. S1-S5
Supplementary Figure SF9 from Radiological Evaluation of Newly Diagnosed Non-Brainstem Pediatric High-Grade Glioma in the HERBY Phase II Trial
Authors: Rodriguez Gutierrez Daniel , Jones Chris , Varlet Pascale , Mackay Alan , Warren Daniel , Warmuth-Metz Monika , Aliaga Esther Sánchez , Calmon Raphael , Hargrave Darren R. , Cañete Adela , Massimino Maura , Azizi Amedeo A. , Le Deley Marie-Cécile , Saran Frank , Rousseau Raphael F. , Zahlmann Gudrun , Garcia Josep , Vassal Gilles , Grill Jacques , Morgan Paul S. , Jaspan Tim
Published: April 2023

Example of Pseudoprogression
Supplementary Figure SF6 from Radiological Evaluation of Newly Diagnosed Non-Brainstem Pediatric High-Grade Glioma in the HERBY Phase II Trial
Authors: Rodriguez Gutierrez Daniel , Jones Chris , Varlet Pascale , Mackay Alan , Warren Daniel , Warmuth-Metz Monika , Aliaga Esther Sánchez , Calmon Raphael , Hargrave Darren R. , Cañete Adela , Massimino Maura , Azizi Amedeo A. , Le Deley Marie-Cécile , Saran Frank , Rousseau Raphael F. , Zahlmann Gudrun , Garcia Josep , Vassal Gilles , Grill Jacques , Morgan Paul S. , Jaspan Tim
Published: April 2023

Significantly different radiological characteristics of H3 G34-mutant compared to other Cerebral wild-type cases
Supplementary Figure SF4 from Radiological Evaluation of Newly Diagnosed Non-Brainstem Pediatric High-Grade Glioma in the HERBY Phase II Trial
Authors: Rodriguez Gutierrez Daniel , Jones Chris , Varlet Pascale , Mackay Alan , Warren Daniel , Warmuth-Metz Monika , Aliaga Esther Sánchez , Calmon Raphael , Hargrave Darren R. , Cañete Adela , Massimino Maura , Azizi Amedeo A. , Le Deley Marie-Cécile , Saran Frank , Rousseau Raphael F. , Zahlmann Gudrun , Garcia Josep , Vassal Gilles , Grill Jacques , Morgan Paul S. , Jaspan Tim
Published: April 2023

Radiological necrosis in a cerebral Grade III tumor
Supplementary Figure SF2 from Radiological Evaluation of Newly Diagnosed Non-Brainstem Pediatric High-Grade Glioma in the HERBY Phase II Trial
Authors: Rodriguez Gutierrez Daniel , Jones Chris , Varlet Pascale , Mackay Alan , Warren Daniel , Warmuth-Metz Monika , Aliaga Esther Sánchez , Calmon Raphael , Hargrave Darren R. , Cañete Adela , Massimino Maura , Azizi Amedeo A. , Le Deley Marie-Cécile , Saran Frank , Rousseau Raphael F. , Zahlmann Gudrun , Garcia Josep , Vassal Gilles , Grill Jacques , Morgan Paul S. , Jaspan Tim
Published: April 2023

Histone status vs imaging characteristics
Figure S8 from Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and fms-like Tyrosine Kinase 3 Ligand (TK/Flt3L) Gene Therapy in a Mouse Model of High-Grade Brainstem Glioma
Authors: Mendez Flor , Kadiyala Padma , Nunez Felipe J. , Carney Stephen , Nunez Fernando M. , Gauss Jessica C. , Ravindran Ramya , Pawar Sheeba , Edwards Marta , Garcia-Fabiani Maria Belen , Haase Santiago , Lowenstein Pedro R. , Castro Maria G.
Published: April 2023

Liver histology and blood cell counts to assess systemic toxicicty
Supplementary Table 8 from Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell Leukemia
Authors: Laurent Anouchka P. , Siret Aurélie , Ignacimouttou Cathy , Panchal Kunjal , Diop M'Boyba , Jenni Silvia , Tsai Yi-Chien , Roos-Weil Damien , Aid Zakia , Prade Nais , Lagarde Stephanie , Plassard Damien , Pierron Gaelle , Daudigeos Estelle , Lecluse Yann , Droin Nathalie , Bornhauser Beat C. , Cheung Laurence C. , Crispino John D. , Gaudry Muriel , Bernard Olivier A. , Macintyre Elizabeth , Barin Bonnigal Carole , Kotecha Rishi S. , Geoerger Birgit , Ballerini Paola , Bourquin Jean-Pierre , Delabesse Eric , Mercher Thomas , Malinge Sebastien
Published: April 2023

Reagents and Resources
Supplementary Table 7 from Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell Leukemia
Authors: Laurent Anouchka P. , Siret Aurélie , Ignacimouttou Cathy , Panchal Kunjal , Diop M'Boyba , Jenni Silvia , Tsai Yi-Chien , Roos-Weil Damien , Aid Zakia , Prade Nais , Lagarde Stephanie , Plassard Damien , Pierron Gaelle , Daudigeos Estelle , Lecluse Yann , Droin Nathalie , Bornhauser Beat C. , Cheung Laurence C. , Crispino John D. , Gaudry Muriel , Bernard Olivier A. , Macintyre Elizabeth , Barin Bonnigal Carole , Kotecha Rishi S. , Geoerger Birgit , Ballerini Paola , Bourquin Jean-Pierre , Delabesse Eric , Mercher Thomas , Malinge Sebastien
Published: April 2023

Differentially expressed genes in the human B-ALL cohort
Figure S1 from Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and fms-like Tyrosine Kinase 3 Ligand (TK/Flt3L) Gene Therapy in a Mouse Model of High-Grade Brainstem Glioma
Authors: Mendez Flor , Kadiyala Padma , Nunez Felipe J. , Carney Stephen , Nunez Fernando M. , Gauss Jessica C. , Ravindran Ramya , Pawar Sheeba , Edwards Marta , Garcia-Fabiani Maria Belen , Haase Santiago , Lowenstein Pedro R. , Castro Maria G.
Published: April 2023

Plasmid map of ACVR1 G328V Sleeping Beauty plasmid
Table S1, Table S2, Fig S1, Fig S2, Fig S3, Fig S4 from First-in-Human Assessment of cRGD-ZW800-1, a Zwitterionic, Integrin-Targeted, Near-Infrared Fluorescent Peptide in Colon Carcinoma
Authors: de Valk Kim S. , Deken Marion M. , Handgraaf Henricus J.M. , Bhairosingh Shadhvi S. , Bijlstra Okker D. , van Esdonk Michiel J. , Terwisscha van Scheltinga Anton G.T. , Valentijn A. Rob P.M. , March Taryn L. , Vuijk Jaap , Peeters Koen C.M.J. , Holman Fabian A. , Hilling Denise E. , Mieog J. Sven D. , Frangioni John V. , Burggraaf Jacobus , Vahrmeijer Alexander L.
Published: April 2023

Supplementary Data
eFigure 2 from Amphiregulin Expression Is a Predictive Biomarker for EGFR Inhibition in Metastatic Colorectal Cancer: Combined Analysis of Three Randomized Trials
Authors: Stahler Arndt , Stintzing Sebastian , Modest Dominik P. , Ricard Ingrid , Giessen-Jung Clemens , Kapaun Christine , Ivanova Boryana , Kaiser Florian , Fischer von Weikersthal Ludwig , Moosmann Nicolas , Schalhorn Andreas , Stauch Martina , Kiani Alexander , Held Swantje , Decker Thomas , Moehler Markus , Neumann Jens , Kirchner Thomas , Jung Andreas , Heinemann Volker
Published: April 2023

Data distribution of amphiregulin (AREG) and epiregulin (EREG) mRNA expression in the three randomized controlled trials FIRE-1, CIOX and FIRE-3. Logarithmic mRNA expression of AREG (A) was parametric distributed and could be normalized to a homogenous collective on which consistent threshold values could be applied (B). Logarithmic mRNA expression of EREG was non-parametric distributed (C) and could not be normalized to a homogenous collective (D)
Supplementary Data from ESR1 Mutations and Overall Survival on Fulvestrant versus Exemestane in Advanced Hormone Receptor–Positive Breast Cancer: A Combined Analysis of the Phase III SoFEA and EFECT Trials
Authors: Turner Nicholas C. , Swift Claire , Kilburn Lucy , Fribbens Charlotte , Beaney Matthew , Garcia-Murillas Isaac , Budzar Aman U. , Robertson John F.R. , Gradishar William , Piccart Martine , Schiavon Gaia , Bliss Judith M. , Dowsett Mitch , Johnston Stephen R.D. , Chia Stephen K.
Published: April 2023

Supplementary Data
Supplementary Figure S8 from Biomarkers Associated with Beneficial PD-1 Checkpoint Blockade in Non–Small Cell Lung Cancer (NSCLC) Identified Using High-Plex Digital Spatial Profiling
Authors: Zugazagoitia Jon , Gupta Swati , Liu Yuting , Fuhrman Kit , Gettinger Scott , Herbst Roy S. , Schalper Kurt A. , Rimm David L.
Published: April 2023

A-B. PFS according to CD56+/CD3- cell counts in stroma (A) and CD56+/CD3+ cell counts in stroma (B); C-D. OS according to CD56+/CD3- cell counts in stroma (C) and CD56+/CD3+ cell counts in stroma (D)
Figure S2 from Genomic Profiling of Prostate Cancers from Men with African and European Ancestry
Authors: Koga Yusuke , Song Hanbing , Chalmers Zachary R. , Newberg Justin , Kim Eejung , Carrot-Zhang Jian , Piou Daphnee , Polak Paz , Abdulkadir Sarki A. , Ziv Elad , Meyerson Matthew , Frampton Garrett M. , Campbell Joshua D. , Huang Franklin W.
Published: April 2023

Associations of recurrent amplification events with race and Gleason score. Left: Frequencies of copy number amplifications are shown for AFR and EUR men (AFR: 171, EUR: 626). A purple dot indicates a significant association with race (FDR < 0.05). Top-right: FGFR1 amplification frequencies are shown for AFR and EUR men stratified by Gleason score. Bottom-right: MYC amplification frequencies are shown for AFR and EUR men stratified by Gleason score.
Supplementary Figure S2 from Biomarkers Associated with Beneficial PD-1 Checkpoint Blockade in Non–Small Cell Lung Cancer (NSCLC) Identified Using High-Plex Digital Spatial Profiling
Authors: Zugazagoitia Jon , Gupta Swati , Liu Yuting , Fuhrman Kit , Gettinger Scott , Herbst Roy S. , Schalper Kurt A. , Rimm David L.
Published: April 2023

Representative histograms showing normalized STING counts (A) and signal to background ratios (B) in the tumor compartment, and normalized CD3 counts (C) and signal to background ratios (D) in the CD45 compartment, as representative markers with high signal relative to non-specific counts
Supplementary Figure S1 from Biomarkers Associated with Beneficial PD-1 Checkpoint Blockade in Non–Small Cell Lung Cancer (NSCLC) Identified Using High-Plex Digital Spatial Profiling
Authors: Zugazagoitia Jon , Gupta Swati , Liu Yuting , Fuhrman Kit , Gettinger Scott , Herbst Roy S. , Schalper Kurt A. , Rimm David L.
Published: April 2023

Study flowchart for spatially-resolved immune biomarker discovery in YTMA404 cohort
Table S4 from Safety, Efficacy, and Biomarker Analysis of Toripalimab in Previously Treated Advanced Melanoma: Results of the POLARIS-01 Multicenter Phase II Trial
Authors: Tang Bixia , Chi Zhihong , Chen Yingbo , Liu Xiufeng , Wu Di , Chen Jing , Song Xin , Wang Weifeng , Dong Lihou , Song Haifeng , Wu Hai , Feng Hui , Yao Sheng , Qin Shuikui , Zhang Xiaoshi , Guo Jun
Published: April 2023

Additional biomarker and subgroup analysis for correlation with clinical efficacy in 127 patients.
Table S3 from Safety, Efficacy, and Biomarker Analysis of Toripalimab in Previously Treated Advanced Melanoma: Results of the POLARIS-01 Multicenter Phase II Trial
Authors: Tang Bixia , Chi Zhihong , Chen Yingbo , Liu Xiufeng , Wu Di , Chen Jing , Song Xin , Wang Weifeng , Dong Lihou , Song Haifeng , Wu Hai , Feng Hui , Yao Sheng , Qin Shuikui , Zhang Xiaoshi , Guo Jun
Published: April 2023

Frequencies of BRAF, NF1, KIT and NRAS mutations and CCND1 amplification by whole exome sequencing from 98 available patients.
Supplementary Table 1 from STAT3 Antisense Oligonucleotide Remodels the Suppressive Tumor Microenvironment to Enhance Immune Activation in Combination with Anti–PD-L1
Authors: Proia Theresa A. , Singh Maneesh , Woessner Richard , Carnevalli Larissa , Bommakanti Gayathri , Magiera Lukasz , Srinivasan Srimathi , Grosskurth Shaun , Collins Mike , Womack Chris , Griffin Matthew , Ye Minwei , Cantin Susan , Russell Deanna , Xie Mingchao , Hughes Adina , Deng Nanhua , Mele Deanna A. , Fawell Stephen , Barry Simon , Reimer Corinne , Barrett J. Carl , McCoon Patricia
Published: April 2023

Patient sample details
Figure S10. from Plasma IL8 Is a Biomarker for TAK1 Activation and Predicts Resistance to Nanoliposomal Irinotecan in Patients with Gemcitabine-Refractory Pancreatic Cancer
Authors: Merz Valeria , Zecchetto Camilla , Santoro Raffaela , Simionato Francesca , Sabbadini Fabio , Mangiameli Domenico , Piro Geny , Cavaliere Alessandro , Deiana Michela , Valenti Maria Teresa , Bazan Diana , Fedele Vita , Lonardi Sara , Melisi Davide
Published: April 2023

The differences in mean overall survival duration of patients in the discovery cohort are estimated for each value of eotaxin (A), GM-CSF (B), Gro-alpha (C), IL-12p70 (D), IL-13 (E), IL-18 (F), IL-1 beta (G), IL-2 (H), IL-4 (I), IL-5 (J), IL-6 (K), IFN gamma (L), IP-10 (M), MCP-1 (N), MIP-1alpha (O), MIP-1 beta(P), RANTES (Q), SDF-1alpha (R) and TNF-alpha (S).
Supplementary Figure 3 from MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial
Authors: Sarker Debashis , Plummer Ruth , Meyer Tim , Sodergren Mikael H. , Basu Bristi , Chee Cheng Ean , Huang Kai-Wen , Palmer Daniel H. , Ma Yuk Ting , Evans T.R. Jeff , Spalding Duncan R.C. , Pai Madhava , Sharma Rohini , Pinato David J. , Spicer James , Hunter Sarah , Kwatra Vineet , Nicholls Joanna P. , Collin David , Nutbrown Robert , Glenny Helen , Fairbairn Sonia , Reebye Vikash , Voutila Jon , Dorman Stephanie , Andrikakou Pinelopi , Lloyd Peter , Felstead Steve , Vasara Jenni , Habib Robert , Wood Chris , Saetrom Pal , Huber Hans E. , Blakey David C. , Rossi John J. , Habib Nagy
Published: April 2023

Longitudinal changes in WBC mRNA expression of CEBPA, adenosine, PD-1 & CXCR4 at screening, day2, 8 and 15 of a single patient treated in the 130mg/m2 cohort
Supplementary Table S2 from Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study
Authors: Autio Karen A. , Klebanoff Christopher A. , Schaer David , Kauh John Sae Wook , Slovin Susan F. , Adamow Matthew , Blinder Victoria S. , Brahmachary Manisha , Carlsen Michelle , Comen Elizabeth , Danila Daniel C. , Doman Thompson N. , Durack Jeremy C. , Fox Josef J. , Gluskin Jill S. , Hoffman David M. , Kang Suhyun , Kang Praneet , Landa Jonathan , McAndrew Philomena F. , Modi Shanu , Morris Michael J. , Novosiadly Ruslan , Rathkopf Dana E. , Sanford Rachel , Chapman Sonya C. , Tate Courtney M. , Yu Danni , Wong Phillip , McArthur Heather L.
Published: April 2023

Summary of noncompartmental pharmacokinetic parameters following intravenous infusion of LY3022855.
Supplementary Table S9 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer
Authors: Liu Bin , Ricarte Filho Julio , Mallisetty Apurva , Villani Cassandra , Kottorou Anastasia , Rodgers Kristen , Chen Chen , Ito Tomoaki , Holmes Kyla , Gastala Nicole , Valyi-Nagy Klara , David Odile , Gaba Ron C. , Ascoli Christian , Pasquinelli Mary , Feldman Lawrence E. , Massad Malek G. , Wang Tza-Huei , Jusue-Torres Ignacio , Benedetti Enrico , Winn Robert A. , Brock Malcolm V. , Herman James G. , Hulbert Alicia
Published: April 2023

Gene Methylation Detection, Sensitivity, Specificity Using Detectable vs. Non-detectable cutoff in blacks
Supplementary Table S5 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer
Authors: Liu Bin , Ricarte Filho Julio , Mallisetty Apurva , Villani Cassandra , Kottorou Anastasia , Rodgers Kristen , Chen Chen , Ito Tomoaki , Holmes Kyla , Gastala Nicole , Valyi-Nagy Klara , David Odile , Gaba Ron C. , Ascoli Christian , Pasquinelli Mary , Feldman Lawrence E. , Massad Malek G. , Wang Tza-Huei , Jusue-Torres Ignacio , Benedetti Enrico , Winn Robert A. , Brock Malcolm V. , Herman James G. , Hulbert Alicia
Published: April 2023

Gene Methylation Detection, Sensitivity, Specificity Using Detectable vs. Non-detectable cutoff in NSCLC late stages
Supplementary Table S10 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer
Authors: Liu Bin , Ricarte Filho Julio , Mallisetty Apurva , Villani Cassandra , Kottorou Anastasia , Rodgers Kristen , Chen Chen , Ito Tomoaki , Holmes Kyla , Gastala Nicole , Valyi-Nagy Klara , David Odile , Gaba Ron C. , Ascoli Christian , Pasquinelli Mary , Feldman Lawrence E. , Massad Malek G. , Wang Tza-Huei , Jusue-Torres Ignacio , Benedetti Enrico , Winn Robert A. , Brock Malcolm V. , Herman James G. , Hulbert Alicia
Published: April 2023

Univariate and multivariate logistic regression analysis for risk of having NSCLC in Whites (n=52)
Figure S5 from Probody Therapeutic Design of 89Zr-CX-072 Promotes Accumulation in PD-L1–Expressing Tumors Compared to Normal Murine Lymphoid Tissue
Authors: Giesen Danique , Broer Linda N. , Lub-de Hooge Marjolijn N. , Popova Irina , Howng Bruce , Nguyen Margaret , Vasiljeva Olga , de Vries Elisabeth G.E. , Pool Martin
Published: April 2023

In vitro PD-L1 expression versus ex vivo uptake in MC38 and MDA-MB-231 tumors.
Figure S5 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer
Authors: Liu Bin , Ricarte Filho Julio , Mallisetty Apurva , Villani Cassandra , Kottorou Anastasia , Rodgers Kristen , Chen Chen , Ito Tomoaki , Holmes Kyla , Gastala Nicole , Valyi-Nagy Klara , David Odile , Gaba Ron C. , Ascoli Christian , Pasquinelli Mary , Feldman Lawrence E. , Massad Malek G. , Wang Tza-Huei , Jusue-Torres Ignacio , Benedetti Enrico , Winn Robert A. , Brock Malcolm V. , Herman James G. , Hulbert Alicia
Published: April 2023

Figure S5
Figure S2 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer
Authors: Liu Bin , Ricarte Filho Julio , Mallisetty Apurva , Villani Cassandra , Kottorou Anastasia , Rodgers Kristen , Chen Chen , Ito Tomoaki , Holmes Kyla , Gastala Nicole , Valyi-Nagy Klara , David Odile , Gaba Ron C. , Ascoli Christian , Pasquinelli Mary , Feldman Lawrence E. , Massad Malek G. , Wang Tza-Huei , Jusue-Torres Ignacio , Benedetti Enrico , Winn Robert A. , Brock Malcolm V. , Herman James G. , Hulbert Alicia
Published: April 2023

Figure S2
Figure S1 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer
Authors: Liu Bin , Ricarte Filho Julio , Mallisetty Apurva , Villani Cassandra , Kottorou Anastasia , Rodgers Kristen , Chen Chen , Ito Tomoaki , Holmes Kyla , Gastala Nicole , Valyi-Nagy Klara , David Odile , Gaba Ron C. , Ascoli Christian , Pasquinelli Mary , Feldman Lawrence E. , Massad Malek G. , Wang Tza-Huei , Jusue-Torres Ignacio , Benedetti Enrico , Winn Robert A. , Brock Malcolm V. , Herman James G. , Hulbert Alicia
Published: April 2023

Figure S1
Supplementary Data from Harmonizing Cell-Free DNA Collection and Processing Practices through Evidence-Based Guidance
Authors: Greytak Sarah R. , Engel Kelly B. , Parpart-Li Sonya , Murtaza Muhammed , Bronkhorst Abel J. , Pertile Mark D. , Moore Helen M.
Published: April 2023

Guidelines discussed in article
Supplementary Data from CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes
Authors: Leuci Valeria , Donini Chiara , Grignani Giovanni , Rotolo Ramona , Mesiano Giulia , Fiorino Erika , Gammaitoni Loretta , D'Ambrosio Lorenzo , Merlini Alessandra , Landoni Elisa , Medico Enzo , Capellero Sonia , Giraudo Lidia , Cattaneo Giulia , Iaia Ilenia , Pignochino Ymera , Basiricò Marco , Vigna Elisa , Pisacane Alberto , Fagioli Franca , Ferrone Soldano , Aglietta Massimo , Dotti Gianpietro , Sangiolo Dario
Published: April 2023

Supplemental Table 1. Phenotypic characterization of patient-derived CSPG4-CAR.CIK and unmodified NTD.CIK
Figure S2 from A Prognostic Model Based on PAM50 and Clinical Variables (PAM50MET) for Metastatic Hormone Receptor–positive HER2-negative Breast Cancer
Authors: Prat Aleix , Tsai Yi-Hsuan , Pascual Tomás , Paré Laia , Adamo Barbara , Vidal Maria , Brasó-Maristany Fara , Galván Patricia , Brase Jan Christoph , Rodrik-Outmezguine Vanessa , Johnston Stephen , Ciruelos Eva , Parker Joel S.
Published: April 2023

Survival outcomes based on the PAM50MET score in the EGF30008 trial. (A) Progression-free survival using a predefined cutoff in patients treated with placebo. (B) Progression-free survival using a predefined cutoff in patients treated with lapatinib. (C) Overall survival using a predefined cutoff in patients treated with placebo. (D) Overall survival using a predefined cutoff in patients treated with lapatinib. Interaction tests between PAM50 and treatment arm for PFS and OS were statistically non-significant (all p-values >0.05). PAM50MET, final model.
Supplementary methods from Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast Cancer
Authors: Crosby Erika J. , Acharya Chaitanya R. , Haddad Anthony-Fayez , Rabiola Christopher A. , Lei Gangjun , Wei Jun-Ping , Yang Xiao-Yi , Wang Tao , Liu Cong-Xiao , Wagner Kay U. , Muller William J. , Chodosh Lewis A. , Broadwater Gloria , Hyslop Terry , Shepherd Jonathan H. , Hollern Daniel P. , He Xiaping , Perou Charles M. , Chai Shengjie , Ashby Benjamin K. , Vincent Benjamin G. , Snyder Joshua C. , Force Jeremy , Morse Michael A. , Lyerly Herbert K. , Hartman Zachary C.
Published: April 2023

Supplementary methods
Figure S6 from Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast Cancer
Authors: Crosby Erika J. , Acharya Chaitanya R. , Haddad Anthony-Fayez , Rabiola Christopher A. , Lei Gangjun , Wei Jun-Ping , Yang Xiao-Yi , Wang Tao , Liu Cong-Xiao , Wagner Kay U. , Muller William J. , Chodosh Lewis A. , Broadwater Gloria , Hyslop Terry , Shepherd Jonathan H. , Hollern Daniel P. , He Xiaping , Perou Charles M. , Chai Shengjie , Ashby Benjamin K. , Vincent Benjamin G. , Snyder Joshua C. , Force Jeremy , Morse Michael A. , Lyerly Herbert K. , Hartman Zachary C.
Published: April 2023

Supplementary Figure 6
Supplementary table 1 from Nectin-2 Expression on Malignant Plasma Cells Is Associated with Better Response to TIGIT Blockade in Multiple Myeloma
Authors: Lozano Ester , Mena Mari-Pau , Díaz Tania , Martin-Antonio Beatriz , León Sheila , Rodríguez-Lobato Luis-Gerardo , Oliver-Caldés Aina , Cibeira Maria Teresa , Bladé Joan , Prat Aleix , Rosiñol Laura , Fernández de Larrea Carlos
Published: April 2023

Supplementary Table S1. Clinical and lab patient characteristics
Supplementary Legend from Nectin-2 Expression on Malignant Plasma Cells Is Associated with Better Response to TIGIT Blockade in Multiple Myeloma
Authors: Lozano Ester , Mena Mari-Pau , Díaz Tania , Martin-Antonio Beatriz , León Sheila , Rodríguez-Lobato Luis-Gerardo , Oliver-Caldés Aina , Cibeira Maria Teresa , Bladé Joan , Prat Aleix , Rosiñol Laura , Fernández de Larrea Carlos
Published: April 2023

Supplementary Legend